Upcoming at FDA Matters

Columns to expect this week and next:

• Update on Follow-on Biologics and the Dance of Legislation
  
• Status of FDA Appropriations
  
• How FDA Could Be Affected by Health Reform Legislation
  
• Exploring the Office of Regulatory Affairs